Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Advanced Solid Tumor × Paclitaxel × Thoracic × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 6 Thoracic 1

Conditions

Carcinoma, Non-Small-Cell Lung 489 Lung Neoplasms 208 Adenocarcinoma of Lung 49 Small Cell Lung Carcinoma 34 Neoplasms 31 Adenocarcinoma, Bronchiolo-Alveolar 25 Neoplasm Metastasis 20 Breast Neoplasms 20 Ovarian Neoplasms 19 Colorectal Neoplasms 16 Carcinoma 14 Squamous Cell Carcinoma of Head and Neck 13 Parkinson Disease 4, Autosomal Dominant Lewy Body 13 Melanoma 13 Carcinoma, Ovarian Epithelial 12 Stomach Neoplasms 11 Carcinoma, Renal Cell 9 Head and Neck Neoplasms 8 Respiratory Tract Neoplasms 7 Prostatic Neoplasms 7 Pancreatic Neoplasms 7 Endometrial Neoplasms 7 Thoracic Neoplasms 6 Pleural Effusion, Malignant 6 Lung Diseases 6 Esophageal Neoplasms 6 Colonic Neoplasms 6 Carcinoma, Squamous Cell 6 Adenocarcinoma 6 Non-Squamous Non-Small Cell Lung Cancer 5

Interventions

pembrolizumab 1 olaparib 1 atezolizumab 1 adagrasib 1 Pemetrexed 1 Paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05117476 2025-11-24

MICA

Cullinan Therapeutics Inc.

Phase 1 Active not recruiting

Other solid neoplasmThoracic

Advanced Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡